Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Showing 1–5 of 5 articles · Keyword: gene editing Clear keyword

Biomaterials2026ResearchNon-viral Gene DeliveryDrug Delivery

1. Transcription activator-like effector base editing delivered by a targeted lipid nanoparticle for therapy of lung cancer

Chen Y, Li P, Xie Y, Wujieti B, Cui W, Zhang H, Et Al.

Lung cancer is the leading cause of cancer-related deaths worldwide. Among them, non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases, while the mutation of KRAS oncogene plays a crucial role in its formation and metastasis. Here, we report a transcription activator-like effector (TALE) base…

Read the article
Applied microbiology and biotechnology2026ResearchNon-viral Gene DeliveryDrug Delivery

2. T cell engineering by targeted small extracellular vesicles delivering CRISPR/Cas9 system for PD-1 knock-out

Farahani Ms, Shamsara M, Moazzeni Sm, Khalili S, Johnson B, Darzi L, Et Al.

Among the emerging cancer therapies, immunotherapy using T cell engineering stands out as one of the most promising approaches. While the clustered regularly interspaced palindromic repeats (CRISPR/Cas) system is widely recognized as one of the most common gene-editing system tools, the main challenge for in vivo…

Read the article
Advanced science (Weinheim, Baden-Wurttemberg, Germany)2026ResearchNon-viral Gene DeliveryDrug Delivery

3. In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma

He L, Yu D, Xie F, Hou K, Li Z, Dai M, Et Al.

Despite the remarkable clinical success of immunotherapy, its efficacy against hepatocellular carcinoma (HCC) remains severely limited, highlighting an urgent need for novel targets and strategies to overcome immune evasion. Here, we aimed to identify key regulators of HCC immunity via unbiased functional screening…

Read the article
Nanomaterials2021ResearchNon-viral Gene Delivery

4. Encapsulation of Large-Size Plasmids in PLGA Nanoparticles for Gene Editing: Comparison of Three Different Synthesis Methods

Tresa Lopez-Royo, Victor Sebastian, Laura Moreno-Martinez, Laura Uson, Cristina Yus, Teresa Alejo, Pilar Zaragoza, Rosario Osta, Manuel Arruebo, Raquel Manzano

CRISPR/Cas gene-editing components are often encoded on large plasmids (9–19 kb), which are difficult to encapsulate and transfect. Most PLGA nanoparticle (NP) gene-delivery studies use small nucleic acids (siRNA) or small plasmids (<6 kb), and the structural integrity and functional performance of large plasmids in…

Read the article
Biomaterials Science2019ResearchNon-viral Gene Delivery

5. Identifying Key Barriers in Cationic Polymer Gene Delivery to Human T Cells

Brynn R. Olden, Emmeline Cheng, Yilong Cheng, Suzie H. Pun

T cells are an important target for ex vivo gene delivery and editing, but most commercial reagents cannot transfect them and cationic polymers show only moderate success. The specific intracellular barriers limiting non-viral gene delivery to human T cells are poorly understood, hindering rational polymer design…

Read the article
Articles | Brilliant Blue Biosciences